» Articles » PMID: 22414897

Transcriptional Integration of Metabolism by the Nuclear Sterol-activated Receptors LXR and FXR

Overview
Date 2012 Mar 15
PMID 22414897
Citations 341
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear receptors are integrators of hormonal and nutritional signals, mediating changes to metabolic pathways within the body. Given that modulation of lipid and glucose metabolism has been linked to diseases including type 2 diabetes, obesity and atherosclerosis, a greater understanding of pathways that regulate metabolism in physiology and disease is crucial. The liver X receptors (LXRs) and the farnesoid X receptors (FXRs) are activated by oxysterols and bile acids, respectively. Mounting evidence indicates that these nuclear receptors have essential roles, not only in the regulation of cholesterol and bile acid metabolism but also in the integration of sterol, fatty acid and glucose metabolism.

Citing Articles

Targeting the ceramidase ACER3 attenuates cholestasis in mice by mitigating bile acid overload via unsaturated ceramide-mediated LXRβ signaling transduction.

Liao L, Liu Z, Liu L, Huang C, Li Y, Mao C Nat Commun. 2025; 16(1):2112.

PMID: 40025008 PMC: 11873283. DOI: 10.1038/s41467-025-57330-7.


Microbial transformations of bile acids and their receptors in the regulation of metabolic dysfunction-associated steatotic liver disease.

Gao Y, Lin J, Ye C, Guo S, Jiang C Liver Res. 2025; 7(3):165-176.

PMID: 39958385 PMC: 11792070. DOI: 10.1016/j.livres.2023.09.002.


Potential therapeutic strategies for MASH: from preclinical to clinical development.

Xie Z, Li Y, Cheng L, Huang Y, Rao W, Shi H Life Metab. 2025; 3(5):loae029.

PMID: 39872142 PMC: 11749562. DOI: 10.1093/lifemeta/loae029.


The fungicide propiconazole induces hepatic steatosis and activates PXR in a mouse model of diet-induced obesity.

Attema B, Kummu O, Krutakova M, Pavek P, Hakkola J, Hooiveld G Arch Toxicol. 2024; 99(3):1203-1221.

PMID: 39718591 DOI: 10.1007/s00204-024-03942-9.


Investigation on regulation of -acetyltransferase 2 expression by nuclear receptors in human hepatocytes.

Hong K, Aureliano A, Walls K, Hein D Front Pharmacol. 2024; 15:1488367.

PMID: 39624836 PMC: 11608957. DOI: 10.3389/fphar.2024.1488367.


References
1.
Ge X, Yin L, Ma H, Li T, Chiang J, Zhang Y . Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis. J Lipid Res. 2011; 52(8):1561-8. PMC: 3137022. DOI: 10.1194/jlr.M015859. View

2.
Kir S, Beddow S, Samuel V, Miller P, Previs S, Suino-Powell K . FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science. 2011; 331(6024):1621-4. PMC: 3076083. DOI: 10.1126/science.1198363. View

3.
Calkin A, Goult B, Zhang L, Fairall L, Hong C, Schwabe J . FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors. Proc Natl Acad Sci U S A. 2011; 108(50):20107-12. PMC: 3250164. DOI: 10.1073/pnas.1111589108. View

4.
van der Velde A, Vrins C, van den Oever K, Kunne C, Oude Elferink R, Kuipers F . Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology. 2007; 133(3):967-75. DOI: 10.1053/j.gastro.2007.06.019. View

5.
Moschetta A, L Bookout A, Mangelsdorf D . Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med. 2004; 10(12):1352-8. DOI: 10.1038/nm1138. View